Lentivirus shRNA, plasmids and lentiviral particles
OriGene offers pre-made lentiviral shRNA plasmid kits containing 4 sequence-verified expression cassettes that target your gene of interest. Each lentiviral cassette contains three major functional elements: shRNA, a puromycin selection marker & a tGFP reporter. With a guaranteed knockdown of ?70%, these kits and our ready-to-use lenti-shRNA particles are a great option for studying long-term gene knockdown.
Key Features and Benefits
- Potent shRNA design ( learn more )
- Genome-wide coverage: Human, Mouse & Rat
- Inducible particles available through custom packaging
- Safety: 3rd generation system with improved biosafety
- Trusted vendor for lentiviral products: view citations
Figure 1: Preparation of lentiviral particles, HEK293T transfection (48 hours). Lenti vector (left) vs Lenti-shRNA targeting tGFP (right).
? Search for Your Lentiviral shRNA Product (browse all)
A detailed look at lentiviral shRNA vector design
pGFP-C-shLenti vector
- Third generation Lentivector
- Chlora marker for bacterial selection
- Three major functional elements within the 5’LTR and
3’LTR. All of them can be packaged to viral particles and
transduced to many cell lines.
- shRNA expression cassette under U6 promoter
- Puromycin resistant for mammalian cell selection
- tGFP gene as reporter.
The shRNA expression cassette
- 29mer hairpin with a 7bp loop.
- U6 driven expression
- A Pol III termination sequence (TTTTTT) immediately downstream of the hairpin.
- The gene-specific shRNA cassette is sequence-verified to ensure its match to the target gene.
Lenti Accessories
Lenti ORF Packaging Kit LentiTran Control Particles Concentrator Lenti Vectors Lenti Titer Kit Stabilizer
Customer Reviews
Recent Citations using our shRNA products
1. Neuronal ER-plasma membrane junctions couple excitation to Ca 2+ -activated PKA signaling Published in Nature Communications, 2023 Aug, using TL708390 |
PubMed: 37633939 |
2. α 1 -Adrenergic receptor–PKC–Pyk2–Src signaling boosts L-type Ca 2+ channel Ca V 1.2 activity and long-term potentiation in rodents Published in eLife, 2023 Jun, using TL710108 |
PubMed: 37338965 |
3. THOC2 expression and its impact on 5-fluorouracil resistance in glioblastoma multiforme Published in American Journal of Cancer Research, 2023 Jun, using TL301111 |
PubMed: 37424800 |